Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Imaging Studies II: Positron Emission Tomography and Scintigraphy01:25

Imaging Studies II: Positron Emission Tomography and Scintigraphy

239
Positron Emission Tomography (PET) is a medical imaging technique that provides crucial insights into the body's physiological functions at a molecular level. It is an indispensable resource for diagnosing, staging, and monitoring various illnesses, notably cancer, neurological disorders, and cardiovascular conditions.
Fundamental Principles of PET
239
Positron Emission Tomography01:29

Positron Emission Tomography

5.9K
Positron emission tomography (PET) is a medical imaging technique involving radiopharmaceuticals — substances that emit short-lived radiation. Although the first PET scanner was introduced in 1961, it took 15 more years before radiopharmaceuticals were combined with the technique and revolutionized its potential.
One of the main requirements of a PET scan is a positron-emitting radioisotope, which is produced in a cyclotron and then attached to a substance used by the part of the body...
5.9K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Long vs. short axial field-of-view PET scanners for brain imaging: a phantom study.

Frontiers in nuclear medicine·2026
Same author

Total Body PET.

Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer·2026
Same author

Validation of a Deep-Learning Coregistration Framework for Long-Axial-Field-of-View PET/CT Using Low-Radiation-Exposure Protocols Across Various Tracers.

Journal of nuclear medicine : official publication, Society of Nuclear Medicine·2026
Same author

Developing Topics.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2025
Same author

Delayed [<sup>89</sup>Zr]Zr-<i>N</i>-Succinyldesferal-Trastuzumab Imaging Enabled by Long-Axial-Field-of-View PET/CT.

Journal of nuclear medicine : official publication, Society of Nuclear Medicine·2025
Same author

Influence of Ultra-Low-Dose CT on PET Image Quantification and Visual Assessment.

Journal of nuclear medicine : official publication, Society of Nuclear Medicine·2025

Related Experiment Video

Updated: Sep 17, 2025

The Bioconjugation and Radiosynthesis of 89Zr-DFO-labeled Antibodies
09:29

The Bioconjugation and Radiosynthesis of 89Zr-DFO-labeled Antibodies

Published on: February 12, 2015

17.5K

Quantification of 89Zr-immunoPET: Methodological considerations.

Philipp Mohr1, Joyce van Sluis1, Adrienne H Brouwers1

  • 1University of Groningen, University Medical Center Groningen, Department of Nuclear Medicine and Molecular Imaging, Groningen, the Netherlands.

Nuclear Medicine and Biology
|July 2, 2025
PubMed
Summary
This summary is machine-generated.

Quantitative analysis of 89Zr-immunoPET imaging using Patlak modeling provides more accurate target engagement assessment than semi-quantitative metrics like SUV, especially with variable antibody kinetics.

Keywords:
Kinetic modellingPET/CTPatlak analysisQuantificationZirconium-89immunoPET

More Related Videos

Positron Emission Tomography Imaging of Cell Trafficking: A Method of Cell Radiolabeling
10:07

Positron Emission Tomography Imaging of Cell Trafficking: A Method of Cell Radiolabeling

Published on: October 27, 2023

1.8K
Determining Binding Affinity KD of Radiolabeled Antibodies to Immobilized Antigens
07:39

Determining Binding Affinity KD of Radiolabeled Antibodies to Immobilized Antigens

Published on: June 23, 2022

6.5K

Related Experiment Videos

Last Updated: Sep 17, 2025

The Bioconjugation and Radiosynthesis of 89Zr-DFO-labeled Antibodies
09:29

The Bioconjugation and Radiosynthesis of 89Zr-DFO-labeled Antibodies

Published on: February 12, 2015

17.5K
Positron Emission Tomography Imaging of Cell Trafficking: A Method of Cell Radiolabeling
10:07

Positron Emission Tomography Imaging of Cell Trafficking: A Method of Cell Radiolabeling

Published on: October 27, 2023

1.8K
Determining Binding Affinity KD of Radiolabeled Antibodies to Immobilized Antigens
07:39

Determining Binding Affinity KD of Radiolabeled Antibodies to Immobilized Antigens

Published on: June 23, 2022

6.5K

Area of Science:

  • Nuclear Medicine
  • Radiopharmaceutical Imaging
  • Pharmacokinetics

Background:

  • Clinical 89Zr-immunoPET imaging commonly uses semi-quantitative metrics like standardized uptake values (SUV).
  • SUV can misinterpret target engagement due to its disregard for plasma and tissue kinetics.
  • Kinetic modeling is rarely applied to 89Zr-immunoPET due to the slow kinetics of monoclonal antibodies (mAbs).

Purpose of the Study:

  • Characterize 89Zr-immunoPET kinetics using a two-tissue compartment model.
  • Identify factors influencing tracer uptake in 89Zr-immunoPET.
  • Assess the validity of semi-quantitative metrics (SUV, TPR) against kinetic modeling (Patlak analysis).

Main Methods:

  • Simulated realistic plasma input functions with varying clearance rates to represent diverse mAb kinetics and doses.
  • Estimated kinetic rate constants and blood volume fractions from literature.
  • Compared SUV and target-to-plasma ratios (TPR) with Patlak net irreversible uptake rate (Ki) under varied kinetic conditions.

Main Results:

  • Uptake varied with plasma kinetics; fast kinetics showed small specific uptake, while slow kinetics yielded higher signals with increased nonspecific binding.
  • SUV and Ki were influenced by tracer delivery (K1) and binding (k3).
  • Semi-quantitative metrics correlated with Ki within limited kinetic variations, but showed significant variability overall; TPR outperformed SUV in slow kinetics scenarios.
  • Patlak analysis was essential for accurate interpretation when plasma clearance varied significantly.

Conclusions:

  • Patlak analysis offers superior quantitative accuracy for 89Zr-immunoPET by accounting for plasma kinetics and reversible binding.
  • Wider adoption of kinetic modeling in 89Zr-immunoPET can improve quantitative accuracy and inform future study designs.